Fundraising Fox

Prolific Machines

Emeryville, US · Founded 2020 · Delaware corporation · 67 employees on LinkedIn · 13 known investors

Find your way into Prolific Machines

1,650 people in our graph share verified history with the Prolific Machines team — schools, employers, funds. One of them is your warm intro.

Scott Davisunlockedknows Declan Jones · together at University of California, Berkeley (overlapped)
×6knows the team · via University of California, Berkeley
knows the team · via Unreasonable
knows the team · via Harvard University
knows the team · via Whitehead Institute/MIT
knows the team · via Grenoble Ecole de Management

Prolific Machines licenses an optogenetics platform that adds light-based control to cell line development and GMP biomanufacturing, letting biopharma teams retrofit existing bioreactors and hosts to raise titers and manufacture complex molecule formats. It targets biopharmaceutical developers and manufacturers seeking higher productivity on difficult programs without re-platforming.

Founders & leadership

Prolific Machines was founded in 2020 by Maximilian Hörner, Max Huisman, Deniz Kent, Deniz Kent, Ph.D., and Declan Jones.

MHMaximilian Hörner
Maximilian HörnerinFounder
MHMax Huisman
Max HuismaninCo-Founder & CTOMax Huisman holds degrees in Applied Physics from the University of Delft and a PhD in Biomedical Sciences from the University of Massachusetts Medical School. He worked as a postdoctoral researcher at the RNA Therapeutics Institute at UMass Medical School before co-founding Prolific Machines, which develops an optogenetics platform for biopharmaceutical manufacturing.
DKDeniz Kent
Deniz KentinChief Executive Officer & Co-Founder
DKDeniz Kent, Ph.D.
Deniz Kent, Ph.D.inCEO & Co-FounderDeniz Kent holds a Ph.D. and founded Prolific Machines, which develops optogenetics platforms for cell line development and biopharmaceutical manufacturing.
DJDeclan Jones
Declan JonesinCo-Founder & CIOCo-founder and Chief Data Officer of Prolific Machines, an optogenetics platform company for biopharmaceutical manufacturing. Previously a machine learning engineer at Zillow Group where he developed fraud prediction models; holds a B.A. in history and computer science from UC Berkeley with focus on computer graphics and image processing.
SMShahram Misaghi
Shahram MisaghiinShahram Misaghi has spent over a decade in biological sciences research with publications in peer-reviewed journals, developing expertise in hybridoma production, high-throughput screening assays, protein expression and purification, and molecular cloning techniques.
CDChristelle Dagoneau
Christelle DagoneauinChief Business Officer (Interim)Christelle Dagoneau brings 25+ years of experience in global leadership roles at biologics CDMOs, with expertise spanning bioprocessing strategy, business development, and strategic partnerships. She founded CD BioPartners to connect emerging bioprocessing technologies with commercial deployment opportunities in biopharma and biomanufacturing.
ERErik Riley
Erik RileyChief Financial Officer (Interim)
GHGeorge Hosegood
George HosegoodinChief Operating Officer
LPLily Paloma
Lily PalomainVice President, PeopleShe has over a decade of experience in HR leadership at high-growth startups, including roles spanning early-stage development through IPO, with expertise in organizational development, talent acquisition, and people operations.
VJVictor Jones
Victor JonesChief Scientific Officer
VVVidar van der Meijdan
Vidar van der MeijdanVice President, Product

Investors · 13

Also in the syndicate · 5

BreakthroughEnergy VenturesConti VenturesKi Tua FundleadMayfieldThe Ki Tua Fundlead

Funding

SEC filings, press & company announcements

$96.6M disclosed across 2 rounds · 2022–2024

$54.6MraisedMay 2024 · 36 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Arvind GuptaDirector
  • Campbell GrieveDirector
  • Max HuismanExecutive Officer, Director
  • Deniz KentExecutive Officer, Director
  • Cooper RinzlerDirector
Offering amount
$57.6M
Amount sold
$54.6M
First sale
May 2024
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Prolific Machines went on to found or lead other companies.

Competitors · 2

by search overlap

Companies competing with Prolific Machines for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does Prolific Machines do?
Prolific Machines licenses an optogenetics platform that adds light-based control to cell line development and GMP biomanufacturing, letting biopharma teams retrofit existing bioreactors and hosts to raise titers and manufacture complex molecule formats. It targets biopharmaceutical developers and manufacturers seeking higher productivity on difficult programs without re-platforming.
Who founded Prolific Machines?
Prolific Machines was founded by Maximilian Hörner, Max Huisman, Deniz Kent, Deniz Kent, Ph.D., Declan Jones in 2020.
Who are Prolific Machines's investors?
Prolific Machines's investors include Baruch Future Ventures, Breakthrough Energy Ventures, Darco Capital, Mayfield Fund, Solari Capital, Shorewind Capital, SOSV, Tet Ventures.
How much funding has Prolific Machines raised?
Prolific Machines has disclosed $96.6M raised across 2 rounds.
Where is Prolific Machines headquartered?
Prolific Machines is headquartered in Emeryville, US.